Momed Biotech (Hangzhou) Biotechnology Co., Ltd. has completed its office renovation project, which spanned nearly five months and commenced in December 2022. The renovated office area exceeds 1000m². 

In April 2023, amidst much anticipation, Chenzhu Technology officially relocated to the 4th floor of Building 1, Hangzhou Digital Harbor, 600 Hongfeng Road, Linping District, Hangzhou. 

We cordially invite guests from all directions to experience our originality and witness this important moment for Chenzhu Technology.

MoMedis a biotechnology company driven by the mechanism research of drug targets, combined with advanced artificial intelligence technology, dedicated to innovative drug development.

To align with the company's philosophy and founding background, the office renovation adopts a futuristic, modern, and avant-garde style. It strives for minimalism while retaining a sense of design, exuding a strong technological vibe.

Upon entering the main entrance of MoMedis, one's eyes are greeted by a million-level configuration luxury server room, running continuously 24 hours a day, perfectly ensuring the data research and development of MoMedis.

Walking into the corridor adorned with futuristic LED strips, one can feel the cutting-edge office atmosphere of MoMedis. Founded by Professor Bai Chen and Professor Arieh Warshel, MoMedis leads with an international perspective, assembling a world-class research and development team to drive the development of the pharmaceutical technology industry with robust technical prowess.

At MoMedis, work and relaxation go hand in hand, with a comfortable and scenic terrace garden flooded with sunlight. It provides a perfect setting for employees and clients to negotiate and unwind, offering a "vitamin D boost" for the spirits at any time.

As night falls, accompanied by ambient lighting, the terrace becomes a perfect spot for unwinding and strolling around the campus after work, offering a relaxing environment for decompression.

During leisure time, enjoying a cup of coffee at the spacious water bar provides a refreshing environment to recharge one's thoughts.

The design style of the versatile circular roadshow hall is bold and cutting-edge, reflecting MoMedis' spirit of daring exploration and tackling challenges head-on. The research offices for high-level doctoral talents leading the leadership database and artificial intelligence AI algorithm teams, as well as the innovative drug development team, are clean and bright, providing an ideal environment for scientific research.

The public office spaces at MoMedis utilize unconventional materials that are eco-friendly, trendy, and artistic, creating a comfortable and stylish environment with a sustainable attitude.

The extra-large conference room is grand, bright, and spacious, welcoming all clients and partners. Inspiration strikes instantly with a circular glass whiteboard on the background wall, allowing everyone to write and brainstorm ideas at any time. The magnetic display boards for papers and documents make presentations clear and organized at a glance.

Professor Arieh Warshel, the 2013 Nobel Prize laureate in Chemistry and the Chief Scientist at MoMedis, maintains his office in a consistent American style. MoMedis's founder, Professor Bai Chen, has collaborated with Professor Arieh Warshel, the 2013 Nobel Prize laureate in Chemistry, for many years. They have accumulated rich experience and achieved significant results in the field of computational biology and the study of the mechanisms of biological macromolecular systems.

Professor Bai Chen's office is designed with a minimalist and atmospheric style, featuring a spacious layout, fresh air, and bright lighting. It welcomes partners and clients to visit and discuss cooperation in a refreshing environment.

MoMedis provides services through six major technological platforms:

1. High-Performance Mechanism Research Platform

2. High-Throughput Virtual Screening Platform

3. High-Intelligence AI Innovative Drug Design Platform

4. High-Level Molecular Optimization Platform

5. Large-Scale Core Database Platform

6. High-Efficiency Multi-Pipeline Drug Development Platform

These platforms offer a one-stop, full-process service from target protein to innovative drug lead compounds.

At this crucial moment in MoMedis' development, we are deeply grateful for everyone's steadfast support. Relocation marks the beginning of a new journey, and we eagerly anticipate MoMedis' soaring success and ambitious achievements.